To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

NCT06647550 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: HD-6277 100mg
DRUG: HD-6277 50mg
DRUG: HD-6277 25mg
DRUG: Placebo

Sponsor

Hyundai Pharm